STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence
STERIS plc (NYSE:STE) is one of the best medical technology stocks to invest in.
Steris Plc (Old) (STE)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (STE) is currently associated with the following stock: Steris Plc (STE)
Sector: Healthcare
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $125.00 | 50,000 | $6,250,000.00 | 48,895 | 2019-03-21 | Filing | |
| $121.79 | 3,609 | $439,540.11 | 22,331 | 2019-03-01 | Filing | |
| $122.51 | 2,037 | $249,552.87 | 8,663 | 2019-02-20 | Filing | |
| $115.00 | 3,000 | $345,000.00 | 30,796 | 2019-01-25 | Filing | |
| $110.00 | 1,750 | $192,500.00 | 30,796 | 2019-01-11 | Filing |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
STERIS plc (NYSE:STE) Q3 2026 Earnings Call Transcript
Operator: Good day, and welcome to the STERIS plc Third Quarter 2026 Conference Call. All participants will be in a listen-only mode.
STERIS plc (NYSE:STE) Q2 2026 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.
Do You Believe in the Growth Potential of STERIS (STE)?
Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here.
KeyBanc’s Positive View on STERIS (STE) Driven by MedTech Momentum
STERIS plc (NYSE:STE) is one of the best defensive stocks to invest in according to analysts.
STERIS plc (NYSE:STE) Q1 2026 Earnings Call Transcript
Operator: Good day, and welcome to the STERIS plc First Quarter 2026 Conference Call. [Operator Instructions] Please note, this event is being recorded.
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target
Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a 'Hold' rating and a $263 price target.
STERIS plc (NYSE:STE) Q4 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the STERIS plc Fourth Quarter 2025 Conference Call. All participants will be in a listen-only mode.
10 Overlooked Dividend Stocks to Buy Now
In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, it has gradually been overshadowed.
Hedge Fund Resource Center Billionaire Hedge Funds
